MicroRNA‑141‑3p inhibits the progression of oral squamous cell carcinoma via targeting PBX1 through the JAK2/STAT3 pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MicroRNA‑141‑3p inhibits the progression of oral squamous cell carcinoma via targeting PBX1 through the JAK2/STAT3 pathway

Published:2021-12-01 Issue:1 Volume:23 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Cao Mingguo¹,Tian Kebin¹,Sun Weifeng¹,Xu Jun¹,Tang Yu¹,Wu Shilian¹

Affiliation:

1. School of Medicine and Health Sciences, Lishui University, Lishui, Zhejiang 323000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Function and Therapeutic Potential of Non-Coding RNA in Ameloblastoma;OncoTargets and Therapy;2024-08

2. The metabolic reprogramming of γ-aminobutyrate in oral squamous cell carcinoma;BMC Oral Health;2024-04-05

3. PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

4. Regulation of the STAT3 pathway by lupus susceptibility gene Pbx1 in T cells;Molecular Immunology;2024-01

5. Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of oral cancer;Pathology - Research and Practice;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP